Morlock Stephen 4
4 · BioPharmX Corp · Filed Oct 22, 2018
Insider Transaction Report
Form 4
BioPharmX CorpBPMX
Morlock Stephen
Director
Transactions
- Sale
Common stock
2018-10-22$0.18/sh−220,766$39,738→ 0 total - Sale
Common stock
2018-10-18$0.19/sh−439,099$83,429→ 434,857 total - Sale
Common stock
2018-10-19$0.18/sh−214,091$38,536→ 220,766 total - Sale
Common stock
2018-10-22$0.18/sh−251,071$45,193→ 0 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)